Tissue Proteomic Alliance Announced by Expression Pathology and ORIDIS Biomed. PR Newswire | May 4, 2007 | COPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information) Copyright

Companies to Offer Protein Biomarker Discovery and Validation In Tissue

GAITHERSBURG, Maryland, and GRAZ, Austria, May 4 /PRNewswire/ -- Expression Pathology Inc. and ORIDIS Biomed GmbH (Graz, Austria) announced today a strategic alliance to offer tissue microproteomic capabilities for protein biomarker discovery and validation. The relationship combines Expression Pathology's proprietary Liquid Tissue(R) and DIRECTOR(TM) technologies, which enable mass spectrometry-based discovery and measurement of protein biomarkers in archival tissue, with ORIDIS Biomed's ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

	Oridis Biomed GmbH, of Graz, Austria.(Other News To Note) Newspaper article from: BioWorld International ; Oridis Biomed GmbH, of Graz, Austria, and Expression Pathology Inc., of Gaithersburg, Md., formed an alliance...discovery and validation. The relationship combines Expression Pathology's Liquid Tissue and Director technologies...
	ORIDIS Biomed Appoints Wolfgang Senne as Chief Financial Officer. PR Newswire ; ...Austria, October 2 /PRNewswire/ -- ORIDIS Biomed, a biopharmaceutical company developing...Financial Officer. Prior to joining ORIDIS Biomed Wolfgang Senne held various executive...expertise that Wolfgang is bringing to ORIDIS Biomed." said Peter Hecht, PhD, CEO of...
	ORIDIS Biomed Licenses NIH's Proprietary Tissue Micro-Array Technology. PR Newswire ; ...Austria, October 30 /PRNewswire/ -- ORIDIS Biomed, a biopharmaceutical company announced...said Georg Casari, PhD, Head of ORIDIS Biomed's TISSOMICS(TM) business. "This...Arrays are a research tool, within ORIDIS Biomed's TISSOMICS(TM) platform, that...
	Austria's Oridis Biomed names Georg Casari chief information officer.(Brief Article) Newspaper article from: Pharma Marketletter ; Georg Casari has joined Austria's Oridis Biomed as chief information officer.
	MorphoSys Expands Target Discovery Capability in Oridis Biomed Collaboration. PR Newswire ; ...announced today an Agreement with Oridis Biomed Forschungs- und Entwicklungs GmbH...antibodies to candidate targets, which Oridis Biomed will use to carry out high throughput...analysis on a range of human tissues. Oridis Biomed receives a license to the MorphoSys...
	Expression Pathology Raises $6.5 Million to Develop Personalized Medicine Assays for Protein Biomarkers in FFPE Tissue. PR Newswire ; ...April 20 /PRNewswire/ -- Expression Pathology Inc., a leading developer of technology...financing will be used to apply Expression Pathology's patented Liquid Tissue(R...Casey Eitner, President and CEO of Expression Pathology. "We believe the ability of our...
	Expression Pathology Aids Research in Identifying Biomarkers of Lung Cancer Metastasis and Survival.(Disease/Disorder overview) Business Wire ; ...GAITHERSBURG, Md. -- Expression Pathology Inc. (EPI), a leader...date is available from Expression Pathology; for a complimentary download...clearly demonstrates how Expression Pathology's Liquid Tissue MS Protein...
	Expression Pathology Obtains Maryland Funding to Develop Breast Cancer Test. Business Wire ; ...GAITHERSBURG, Md. -- Expression Pathology Inc. (EPI), a leader...at a critical point in Expression Pathology's development," said...positive breast cancer. About Expression Pathology Inc. Formalin-fixed...
	NextGen and EP to offer combined service.(Expression Pathology)(Brief article) Newspaper article from: Pharma Marketletter ; ...provider of biomarker services, and fellow USA-based Expression Pathology, a specialist in tissue protein analysis, have signed...interest. However, the projects run by NextGen and Expression Pathology take less time to complete and do not require antibodies...
	In August, Expression Pathology licensed Harvard University's AQUA.(Life Science Consumables: Company Announcements) Newspaper article from: Instrument Business Outlook ; * In August, Expression Pathology licensed Harvard University's AQUA peptide technology for quantitative analysis of proteins in human and animal tissues.

For more facts and information, see all results

Find more facts and information related to the article "Tissue Proteomic Alliance Announced by Expression ..."